Lung Cancer
New Understandings and Therapies
| Auflage | 2022 |
| Seiten | 264 pp., 17 illus. |
| Verlag | Springer |
| ISBN | 9783030740306 |
| Artikel-Nr. | 621188 |
Lieferzeit ca. 5 Werktage
Produktbeschreibung
Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement.
Highlight recent updates in lung cancer management, both NSCLC and SCLC.
Focus on translational approaches in understanding resistance biology to inform clinical management in patients treated with immuno and targeted therapies
Provide the latest update on understanding and use of biomarkers in the tumor macro and microenvironment and circulating in blood
Focus on changing concepts and use of immunotherapy and radiotherapy in lung cancer as well as in patients with CNS involvement
Highlight recent updates in lung cancer management, both NSCLC and SCLC.
Focus on translational approaches in understanding resistance biology to inform clinical management in patients treated with immuno and targeted therapies
Provide the latest update on understanding and use of biomarkers in the tumor macro and microenvironment and circulating in blood
Focus on changing concepts and use of immunotherapy and radiotherapy in lung cancer as well as in patients with CNS involvement